Ellington Management Group’s Array Biopharma Inc ARRY Stock Holding History

Ellington Management Group’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-11,600	Closed	-$176K	–	686
2018 Q3	$176K	Buy	+11,600	New	+$178K	0.05%	454
2017 Q3	–	Sell	-13,300	Closed	-$111K	–	955
2017 Q2	$111K	Buy	+13,300	New	+$109K	0.02%	590
2016 Q4	–	Sell	-25,000	Closed	-$169K	–	912
2016 Q3	$169K	Buy	+25,000	New	+$96.7K	0.05%	572
2016 Q1	–	Sell	-29,100	Closed	-$123K	–	791
2015 Q4	$123K	Buy	+29,100	New	+$133K	0.04%	531
2015 Q2	–	Sell	-95,000	Closed	-$700K	–	990
2015 Q1	$700K	Buy	+95,000	New	+$676K	0.14%	189

Other funds holding ARRY

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Ellington Management Group's ARRY Position: Q4 2018 in Review

Ellington Management Group sold out of Array Biopharma Inc (ARRY) in Q4 2018, closing a stake of 11,600 shares — an estimated $176K sold.

Ellington Management Group first reported a position in ARRY in Q1 2015 and held it in 5 quarters. The position peaked at $700K in Q1 2015. 236 funds tracked by Wall St. Rank hold ARRY as of Q4 2018.

Ellington Management Group reported no remaining Array Biopharma Inc position as of Q4 2018 after selling out during the quarter.
Ellington Management Group sold 11,600 Array Biopharma Inc shares in Q4 2018, an estimated $176K.
Ellington Management Group first reported a position in Array Biopharma Inc in Q1 2015 and held it in 5 quarters.
Ellington Management Group's Array Biopharma Inc position peaked at $700K in Q1 2015.
236 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q4 2018.

Based on Ellington Management Group's 13F filing for Q4 2018, filed 14 Feb 2019.